Skip to content

Effect of Acupuncture on the Clinical Outcome of IVF-ET in Patients With Recurrent Implantation Failure

Effect of Acupuncture on the Clinical Outcome of IVF-ET in Patients With Recurrent Implantation Failure: a Multicenter Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04822207
Enrollment
310
Registered
2021-03-30
Start date
2021-05-01
Completion date
2023-12-31
Last updated
2021-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acupuncture, Recurrent Implantation Failure

Keywords

acupuncture, recurrent implantation failure

Brief summary

In order to explore the effect of acupuncture on the clinical outcome of IVF-ET in patients with recurrent implantation failure, the patients divide into the experimental group or the control group. In the experimental group, those patients undergo acupuncture at the beginning of embryo transfer cycle three times a week until 14 days after embryo transfer. In the control group, those patients do not receive any treatments during embryo transfer cycle. Statistical analysis of the two groups of primary endpoint and secondary endpoint are done.

Detailed description

In the field of assisted reproduction techonology, there are still 10% of patients with recurrent implantation failure. In order to explore the effect of acupuncture on the clinical outcome of IVF-ET in patients with recurrent implantation failure, the patients divide into the experimental group or the control group. In the experimental group, those patients undergo acupuncture at the beginning of embryo transfer cycle three times a week until 14 days after embryo transfer. In the control group, those patients do not receive any treatments during embryo transfer cycle. Both of two group patients are checked including endometrial receptivity index and fill in SAS anxiety scale form. Statistical analysis of the two groups of primary endpoint (clinical pregnancy rate) and secondary endpoint (embryo implantation rate, biochemical pregnancy rate, early pregnancy loss rate, ongoing pregnancy rate, live birth rate)are done.

Interventions

PROCEDUREacupuncture

Patients undergo acupuncture at the beginning of embryo transfer cycle three times a week until 14 days after embryo transfer. Every acupuncture lasts 20 minutes.

Sponsors

ShangHai Ji Ai Genetics & IVF Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 38 Years
Healthy volunteers
No

Inclusion criteria

1\. A: ≥ 3 times embryo transfer failures,and at least accumulated 4 high-quality embryos were transferred B: Two times consecutive embryo transfers failures, at least accumulated 4 high-quality embryos were transferred 2\. Undergo IVF / ICSI / PGT; 3\. Transfer 1-2 D3 cleavage embryos or blastocysts in IVF / ICSI and transfer 1 blastocyst in PGT; 4\. 20-38 years old female 5\. Sign the informed consent voluntarily.

Exclusion criteria

1. Contraindications for pregnancy or assisted reproductive technology; 2. Chromosome abnormality of husband or wife (except polymorphism); 3. Abnormal gene diseases; 4. Untreated of uterine diseases that affect the uterine cavity morphology (uterine malformation, submucous myoma, adenomyosis, endometriosis and endometriosis etc.); 5. AMH \< 1.1ng/ml or AFC \< 7; 6. The most thickness of endometrium is less than 7 millimeter; 7. Those who have more than 2 times clinical pregnancy abortion; 8. Patients with serious primary diseases including cardiovascular, cerebrovascular, liver, kidney and hematopoietic system and mental diseases 9. The treatment (such as acupuncture and traditional Chinese Medicine) related to help pregnancy had been carried out in the last 3 months.

Design outcomes

Primary

MeasureTime frameDescription
Clinical pregnancy rate6 monthsClinical pregnancy will be defined as ultrasonographic evidence of an intrauterine sac with or without a fetal heart at the 6th gestational week.

Secondary

MeasureTime frameDescription
embryo implantation rate6 monthsThe embryo implantation rate (IR) will be calculated as the number of gestational sacs per embryo transferred
biochemical pregnancy rate6 monthsBiochemical pregnancy will be defined by a serum HCG level ≥5.0 mIU/ml approximately 14 days after embryo transfer
early pregnancy loss rate6 monthsEarly pregnancy loss will be considered pregnancy loss occurring after detection of a clinical pregnancy up to the 12th week of pregnancy
ongoing pregnancy rate6 monthsOPR was calculated by considering all viable intrauterine pregnancy progressing beyond 12 weeks of gestation.
live birth rate12 mongthsLive birth rates were calculated based on the total number of live births \> 20 weeks' gestation over the total number of ongoing pregnancies.

Countries

China

Contacts

Primary ContactWenbi Zhang, Doctor
jackeyzhang0905@163.com+8602163459977
Backup ContactHe Li, Doctor
lihe198900@163.com+8602163459977

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026